liver-cancer

Documents about liver-cancer

• Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization#904543ClinicalTrials.gov
• Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors#970023ClinicalTrials.gov
• Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies#804732ClinicalTrials.gov
• Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases#852067ClinicalTrials.gov
• A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours#870789ClinicalTrials.gov
• Association of Statin Use with Reduced Primary Liver Cancer Risk, Independent of Age and Cirrhosis Protection in MASLD.#9152NCBI PubMed Central
• Study on the Efficacy and Safety of Transarterial Chemoembolization Combined With Targeted Immunotherapy in Patients With Unresectable Hepatocellular Carcinoma#162471ClinicalTrials.gov
• Development of folic acid modified reduction-responsive micelles for the targeted release of sorafenib in liver cancer.#242387NCBI PubMed Central
• (18)F-FDG PET radiomics model for predicting TARE response in patients with colorectal cancer liver metastases.#247580NCBI PubMed Central
• Network pharmacology prediction and experiment validation to discover the mechanism of Sophora japonica Linn. against liver cancer.#247839NCBI PubMed Central
• ADAR1 as a prognostic marker for patients with colorectal cancer and synchronous liver metastasis and a predictor of chemotherapy efficacy#292643OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Artificial intelligence driven exposome and multi omics integration for biomarker discovery in liver cancer: a literature review.#437099NCBI PubMed Central
• Argipressin's Influence on Blood Loss During Hepatic Resection#442055ClinicalTrials.gov
• Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM#838375ClinicalTrials.gov
• Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases#874641ClinicalTrials.gov
• vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC#885252ClinicalTrials.gov
• Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM#907353ClinicalTrials.gov
• Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis#967135ClinicalTrials.gov
• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)#981326ClinicalTrials.gov
• A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy#981963ClinicalTrials.gov
• Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma#800894ClinicalTrials.gov
• Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors#845996ClinicalTrials.gov
• Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial#298593IRIS
• BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer#325301ClinicalTrials.gov
• High-fat, low-carb diet reduces tumor growth and induces liver metabolism remodeling in a breast cancer mouse model#378073HAL (France)
• Thermal ablation of breast cancer liver metastases achieves durable control and prolongs chemotherapy-free survival in selected patients#13837Europe PMC
• ICMT deficiency ameliorates weight loss and mortality, but not tumor formation in a mouse model of liver cancer.#25651NCBI PubMed Central
• Preoperative differentiation of primary liver cancer subtypes: An MRI-based multiclass classification model integrating radiomic and clinicoradiological characteristics.#174638NCBI PubMed Central
• Building an Ontology-Based Cohort of Liver Cancer Imaging Data for AI Development on the European Federated Platform EUCAIM#367416HAL (France)
• Financial toxicity profiles and their associations with healthcare utilization and catastrophic health expenditure in patients with primary liver cancer.#409546NCBI PubMed Central
• Construction and Validation of a Risk Prediction Model for Postoperative Nausea and Vomiting in Patients with Liver Cancer.#465141NCBI PubMed Central
• Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine.#636330NCBI PubMed Central
• NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer#813530ClinicalTrials.gov
• A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer#837648ClinicalTrials.gov
• Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma#839462ClinicalTrials.gov
• Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients#891672ClinicalTrials.gov
• The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study#913428ClinicalTrials.gov
• Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)#1030330ClinicalTrials.gov
• A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions#1044412ClinicalTrials.gov
• Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma#880178ClinicalTrials.gov
• A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy#848589ClinicalTrials.gov
• Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers#904478ClinicalTrials.gov
• A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection#1044175ClinicalTrials.gov
• Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy#831648ClinicalTrials.gov
• HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization#849128ClinicalTrials.gov
• RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial#67869ClinicalTrials.gov
• Machine Learning Models for Predicting Liver Metastasis at Diagnosis and Overall Survival in Ovarian Cancer: A SEER-Based Study.#244278NCBI PubMed Central
• Early mortality risk prediction in critically ill patients with liver cancer using interpretable machine learning: a retrospective cohort study.#436972NCBI PubMed Central
• Disease burden and prediction of liver cancer attributable to metabolic risks in five East Asian countries from 1990 to 2023.#440874NCBI PubMed Central
• Selection of proper artificial intelligence techniques developed for CT scan image analysis of liver cancer using fuzzy AHP-TOPSIS.#678158NCBI PubMed Central